- 1School of Medicine, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa
- 2Department of Health, Limpopo Province, Sekororo District Hospital, Durban, South Africa
Background: Diabetic retinopathy (DR) is a leading cause of preventable vision loss worldwide. Early screening and diagnosis are critical in mitigating vision loss in patients with diabetes. This review aims to analyze existing research on healthcare professionals’ (HCPs) knowledge, attitudes, and practices regarding DR screening.
Methods: A literature search was performed using four electronic databases: Medline, Google Scholar, Science Direct, and EBSCOhost. The search terms included synonyms connected by the Boolean operator “OR.” This search covered quantitative, qualitative, and mixed-methods research studies. The appraisal was done using the Joanna Briggs Institute’s critical tool. A total of 59 published articles were analyzed.
Results: Forty-seven articles (79.7%) assessed knowledge of HCPs, 30 (50.8%) assessed attitudes, and 42 (71.2%) assessed practices related to DR screening and referrals. The studies reveal significant differences in knowledge, attitudes, and practices regarding DR among various HCPs. There was variation in levels of knowledge amongst various categories of HCPs, with nine studies reporting 100% knowledge of DR. Positive attitudes ranged from 13 to 100%. Similar variations were reported regarding practices, with many HCPs not screening patients for DR. Inadequate training, lack of screening resources like an ophthalmoscope, dilating eye drops, and being inundated with other responsibilities were common reasons for the gaps in knowledge and practices.
Conclusion: Non-ophthalmic HCPs’ knowledge, attitudes, and practices (KAP) regarding DR screening were unsatisfactory. The HCPs with an ophthalmic background had varying levels of KAP regarding DR, with some having good knowledge and others having deficiencies in applying screening guidelines and providing patient education. Regular in-service training is needed, particularly for non-ophthalmic HCPs, and resources should be available for screening at the primary care level.
1 Introduction
Diabetes mellitus (DM) is one of the leading non-communicable diseases that contributes to significant morbidity and mortality worldwide (1). The global prevalence of DM is 10.5% impacting around 536.6 million persons, and is expected to increase by 12.2% (783.2 million people) (1). As with many other diseases, the prevalence of DM differs from region to region. As per the International Diabetes Federation, countries in the Middle East, such as Kuwait, Bahrain, Qatar, and Egypt in the North Africa region, report the highest diabetic prevalence at 16.2% (2). The high prevalence of DM in this region is also influenced by a genetic predisposition to insulin resistance among various ethnic groups (3). In North America and the Caribbean region, the prevalence of DM was 14%, followed by Southeast Asia (10%), Western Pacific (9.9%), Europe (9.2%), and South and Central America (8.2%) (2). The lowest prevalence rate of DM is observed in the African region (4.5%), particularly in other countries of Eastern Sub-Saharan, comprising Uganda, Kenya, Malawi, Tanzania, Ethiopia, and Rwanda, with limited published data for some areas, such as in rural areas of Tanzania and Ethiopia, due to an inadequate surveillance system (4).
Diabetic retinopathy (DR) is a prevalent complication of diabetes (5). This is a complex diabetic microvascular complication initiated by chronic hyperglycemia, causing metabolic abnormalities in the retina, including neurodegeneration and inflammation (5). The progression of DR starts with retinal blood vessel damage, then thickening of the basement membrane, loss of pericytes due to apoptosis induced by hyperglycemia weakening capillary walls leaking to microaneurysm formation, and disruption of endothelial function causing fluid to leak from capillaries or blockage in the capillaries leading to cotton-wool spots due to the hypoxia (6). Diabetic retinopathy risk factors are linked to inadequate glycaemic management, diabetes duration, age, nephropathy, high blood pressure, high levels of lipids, obesity, pregnancy, previous eye surgery, and smoking (7).
There are two categories of diabetic retinopathy: non-proliferative and proliferative (5). Non-proliferative diabetic retinopathy (NPDR) is the initial progression stage of DR, and it is an asymptomatic stage characterized by the absence of neovascularization on the retinal sites (5). Proliferative DR (PDR) is the late stage of DR characterized by retinal neovascularization, usually with visual symptoms such as fluctuation of vision or reduced vision, seeing dark spots when looking in an open space due to hemorrhages in the vitreous space (8). Proliferative DR is considered a sight-threatening DR condition requiring urgent medical attention to prevent further vision loss or blindness (5). The healthcare professionals (HCPs) involved in the management of patients at risk for DR must understand the different stages and characteristics of DR so that appropriate interventions are offered promptly to prevent severe vision impairment or blindness. According to the epidemiological data from the global DR barometer, it has been observed that 28% of diabetic patients develop DR, while 42% develop diabetic macular edema (8). These findings emphasize the significance of early detection and treatment of eye issues related to diabetes (8).
In individuals between the ages of 20 and 70 in low- or middle-income countries, DR is the primary reason for blindness or moderate-to-severe vision impairments (1). Nearly 80% of adults, equating to 4.2 million adults, and 655,000 adults have some form of DR, which is more than twice in Mexican Americans and almost three times as common in African Americans (1). Globally, DR had a prevalence of 22.3% according to a 2021 systematic review (9). The prevalence of sight-threatening DR and clinically significant macular edema is 6.2% and 4.1%, respectively (9). Africa and North America have the largest prevalence of DR at 35.9% because of the growing diabetic population, while South and Central America have the smallest prevalence at 13.4% (9). According to a 2021 systematic review, the prevalence of DR in the Sub-Saharan African (SSA) region varies from 13 to 82%, while the sight-threatening DR ranges from 2.1% to 51.4% based on a systematic review reported in 2021 (10).
It is the responsibility of the HCPs managing a patient with diabetes to screen or refer the patient for screening for DR. Healthcare professionals’ knowledge, attitudes, and practices (KAP) of DR screening and referrals play a vital role in preventing vision impairment in people with diabetes. Late screening of patients with diabetes due to poor referral systems can lead to permanent vision impairment or blindness (7). While problems within the healthcare system may lead to delays in the diagnoses and management of patients, a lack of awareness among HCPs regarding the significance of DR screening can also be an important contributory factor (11). Alarmingly, over 37% of diabetic patients globally suffer from DR because of delays in referring them for an eye screening (8).
After critically analyzing the literature discussed, screening for DR appears to be sub-optimal, and there is therefore a need to document the gaps in the existing practices of HCPs regarding DR screening. Whilst previous reviews have looked at the general complications of DM (12), this is the first narrative review to focus specifically on DR. We aimed to evaluate and summarize the key findings of published studies that have investigated knowledge, attitudes, and practices of HCPs regarding DR. This review will offer important insights and strategies to strengthen DR screening. Additional advantages include supporting ongoing training to improve healthcare providers’ comprehension of DR screening and referral procedures. This is especially important for non-ophthalmic providers.
2 Method and materials
2.1 Literature search strategies and eligibility
Before commencing the literature search, the strategy and eligibility for inclusion and exclusion criteria for a review were developed. A systematic search was done to identify published articles on the KAPs of HCPs about DR. Five electronic databases were searched, including Medline (via the PubMed and Ovid interfaces), Google Scholar, Scopus, Science Direct, and EBSCOhost. We used the “building blocks” approach, often used in reviews, to create thorough search strategies. We organized search terms into categories representing different HCPs involved in treating patients with diabetes (including those impacted by DR). We also broadened the search terms by including synonyms and using the Boolean operators to connect them. The keywords include “knowledge OR attitude OR practice, diabetic retinopathy OR diabetic complications, healthcare professionals OR workers OR providers OR physicians OR nurses OR doctors OR general practitioners OR optometrists OR ophthalmologists.” The search was restricted to articles from earlier research studies from 1996 to 2023. Table 1 presents the components of the criteria for inclusion and exclusion.
2.2 Article selection
Following an in-depth search, all retrieved articles were entered into Mendeley 2.110.0 software (2024 Elsevier, Mendeley Ltd., London). The identified duplicates were removed using the duplicates command. Relevant articles were selected in three phases. In phases 1 and 2, the titles and abstracts of articles were screened by the first author (KDM) with the help of two colleagues working in the same organization as KDM, and irrelevant articles were excluded. In phase 3, the full-text manuscripts were carefully assessed. The articles of studies that met pre-defined inclusion criteria in Table 1 were selected. KDM decided to include relevant studies, but the disagreements were discussed to reach a consensus.
2.3 Data extraction and quality assessment
KDM carefully assessed the title and abstract of each study, and data related to the topic were extracted. The quality assessment was done using two Joanna Briggs Institute’s (JBI) critical appraisal tools for methodological appropriateness, including analytic methods, with one revised version containing 8 items for analytical cross-sectional studies, and another containing 10 items for qualitative studies (13). In this review, the level of quality was assessed based on the elements of methodological appropriateness from the JBI critical appraisal tool, with the results included in Supplementary Tables 1 and 2. The quality assessment scores employed for a review include methodologically strong (with <2 missing criteria), moderate (with 2–3 missing criteria), and weak (with >2) (14).
3 Results
3.1 Identification of studies
The initial search identified a total of 237 articles. Following the exclusion of 31 duplicates, the titles, and abstracts of 206 articles of published studies underwent a screening process to identify published articles relevant to this review. Subsequently, 123 articles were excluded based on the pre-defined inclusion criteria (Table 1). In addition, 24 articles were excluded after reviewing the full-text manuscripts as the focus was on the treatment of DR. Finally, 59 published studies were included and analyzed in this review. A summary of the literature search and selection stages has been provided in Figure 1.
3.2 Summary of included studies
The studies included originated from all six World Health Organization (WHO) regions, with the majority (n = 23) being from the Eastern Mediterranean region, followed by 11 from the African region and 10 from the Western Pacific region (Figure 2). There were only three studies that were conducted in the Americas and European regions. In terms of individual countries, 16 studies were conducted in Saudi Arabia, followed by seven in India (15–73). The study settings included public and private healthcare sectors, and the study populations included various categories of HCPs who manage diabetes and DR. The sample sizes ranged from eight HCPs to 710 physicians.
3.3 Study quality
The reviewed studies in this analysis were characterized by clearly defined objectives and the use of the appropriately selected methodologies, as determined through evaluation with the Joanna Briggs Institute’s (JBI) critical appraisal tool (13, 74–76). Thirty-six quantitative studies demonstrated a moderate JBI quality level (16–26, 28–32, 34, 35, 37–41, 43–47, 49, 52–54, 58, 60, 62, 63, 65, 66, 68, 70, 71). The other 18 showed a strong level in Supplementary Table 1 (15, 27, 29, 30, 33, 36, 42, 44, 48, 51, 55, 57, 59, 61, 64, 65, 69, 72). Three qualitative studies demonstrated moderate levels of quality assessment (56, 67, 73), and one showed a strong JBI quality assessment (Supplementary Table 2) (50).
3.4 Categories of healthcare professionals
The HCPs included in this review are primary healthcare nurses, primary care physicians (general practitioners or family physicians, and internists), ophthalmic care professionals (ophthalmologists, optometrists, and ophthalmic nurses), medical residents, diabetologists, dietitians, laboratory scientists, physical therapists, general nursing personnel (professional registered nurses, and staff nurses), paramedical personnel, and other clinical officers involved in the management of diabetes (Table 2). Some of the included studies used the terms “medical practitioner,” “medical officer,” and “physicians” interchangeably when referring to the doctors (17, 19, 20, 22, 24, 25, 28, 29, 32, 40, 41, 50, 52, 53, 61, 66, 69, 73). This review presents all HCPs as described in their respective articles.
3.5 Methods of assessing healthcare professionals’ knowledge, attitudes, and practices
Fifty-three of the 59 studies used a cross-sectional design (15–49, 51–54, 57–66, 68–72, 77–87), five were descriptive qualitative studies (50, 55, 56, 67, 73), and one study employed a mixed-methods approach (28). Fifty-one studies used self-administered structured interview questionnaires with closed-ended questions (15–27, 29, 30, 32–42, 44–46, 49, 51–60, 62–68, 70–72, 77–79, 81–88). Five studies used semi-structured questionnaires with closed and open-ended questions (28, 50, 55, 61, 69), and three studies used unstructured questionnaires (56, 67, 73). The studies employed various methods to gather data, such as paper-based, telephone, and online surveys, and focus group discussions (FGDs) for qualitative research (15–73, 85). Twenty-three studies assessed knowledge, attitudes, and practices (17, 18, 21–24, 28, 31, 32, 39, 40, 43, 53, 57, 58, 61, 63–66, 69, 70, 72, 85), three assessed knowledge and attitudes (25, 37, 52), five assessed knowledge, and practices (20, 26, 29, 59, 62), and one study assessed attitudes and practices toward DR (71). Fourteen studies assessed knowledge only, 10 of which used structured questionnaires comprising “yes/no/I do not know” responses (27, 35, 36, 41, 42, 46–48, 50, 51), one used a questionnaire with “almost never/sometimes/often/almost always/refer somewhere” responses (60), and four were focus group discussions (55, 56, 67, 73). Two studies assessed attitudes only with one study using a structured questionnaire with a 5-point Likert scale (1 = strongly agree, 2 = agree, 3 = neutral, 4 = disagree, 5 = strongly disagree) (30) and the other used a questionnaire with “yes/no/I do not know/not sure” responses (45). Nine studies assessed practices only with seven using questionnaires with “yes/no/I do not know” responses (15, 16, 33, 34, 38, 44, 68), one using a questionnaire with “very confident/not confident/never learn to perform” responses (54), and another one used a questionnaire with 5-point Likert scale responses (49).
3.6 Healthcare professionals’ knowledge of diabetic retinopathy
Of the 59 studies, 47 (79.7%) assessed the knowledge of DR among different categories of HCPs. Most studies (over 90%) utilized a common set of DR knowledge-related questions (17–29, 31, 32, 35–37, 39–43, 46–48, 50–53, 55–67, 69, 70, 72, 73, 85). These questions encompassed various aspects of diabetes and its impact on the retina. Topics included the knowledge of DR prevalence among individuals affected by diabetes, the effects caused by complicated diabetes on vision, eye complications linked to diabetes, the preferred method for evaluating DR in different resource settings, progressive stages of DR with their respective clinical manifestations, and the risk factors were linked to a rapid progression of DR. These risk factors encompass the age, pregnancy, duration of diabetes, body weight, control of blood glucose levels, retinal conditions, hypertension, hyperlipidemia, and renal diseases (17–29, 31, 32, 35–37, 39–43, 46–48, 50–53, 55–67, 69, 70, 72, 73, 85). The knowledge about DR varied among different categories of the HCPs involved in diabetic care, including those providing DR screening services. Most HCPs (93.8%) were aware that diabetes can cause eye damage, leading to irreversible vision impairment or loss.
Nine of the 48 studies reported that 100% of HCPs had a good knowledge of DR, and these studies were from Nigeria, South Africa, the UK, India, Thailand, Kenya, Saudi Arabia, Fiji, and China (65–67, 69, 73). A study conducted in Southern India among 200 paramedical personnel reported that only 2.5% of the 200 paramedical personnel knew about DR. Low proportion was attributed to insufficient educational materials on DR for this category of HCPs (63). In Northwestern Nigeria, 63.2% of the 105 physicians knew the effective method for prolonging the onset and progression of DR (17). In the Canary Islands, the results showed that 68.4% of the 165 sampled PHC nurses knew how to differentiate normal retinal images or photographs from the affected ones (42).
3.7 Attitudes of healthcare professionals toward diabetic retinopathy
Thirty-two studies that evaluated the attitudes of HCPs toward DR screening and referrals utilized common items in the Likert scale format (17, 18, 21–23, 28, 30, 39, 57, 65, 70–72). Some of these items reflected beliefs such as eye examinations are not within the realm of responsibility for the general healthcare providers or primary care physicians, eye-related problems are time-consuming, addressing diabetic retinopathy in an outpatient clinic setting is impractical, and performing fundoscopy without periodic in-service training is not valuable.
The proportion of HCPs with a positive attitude toward DR ranged from 13.2 to 100%. Notably, four studies conducted in Yemen, two in Indonesia, and Pakistan reported that 100% of all HCPs exhibited positive attitudes toward DR screening, including prevention (30, 39, 58, 69). These studies revealed that HCPs demonstrated commendable attitudes toward DR by prioritizing DR screening in diabetic patients. Additionally, HCPs in these studies received specialized training on DR, comprehended its psychological impact, respected the autonomy of diabetic patients, and emphasized the significance of stringent blood glucose control (30, 39, 58, 69). Conversely, a study in Saudi Arabia among 99 primary care physicians (PCPs), revealed that only 13.2% had positive attitudes toward DR (52). The study reported that PCPs believed that well-trained HCPs (the ophthalmologists, optometrists, and ophthalmic nurses) should conduct DR screening, including diagnosing and managing individuals affected by DR effectively, as opposed to the general PCPs, like GPs, family physicians, internists, and other non-ophthalmic practitioners involved in the management of diabetes.
3.8 Healthcare professionals’ practices of diabetic retinopathy
Forty studies used items such as screening for DR among all diabetes patients irrespective of the type, whether a patient was symptomatic, and adherence to standardized diabetic eye screening schedules and referral guidelines. Only 4.3% of Indonesia’s 92 general practitioners (GPs) had followed the DR referral and screening protocols effectively (58). This low proportion of GPs was mainly due to the lack of comprehensive vision testing, the unavailability of vision acuity testing charts and ophthalmic medical technology such as ophthalmoscopes for a basic fundoscopic examination, and an underdeveloped referral system (58). The practice of performing fundoscopy varied among PHC nurses and ophthalmic care practitioners (such as optometrists, ophthalmologists, and ophthalmic nurses) in eight studies conducted across five different regions, including Saudi Arabia, the USA, India, Australia, and South Africa (15, 16, 33, 44, 47, 54, 69, 71). Two South African studies conducted in the eThekwini municipality and the Waterburg and Capricorn Districts reported that all PHC nurses did not implement DR screening programs due to a lack of appropriate skills to perform screening procedures for DR, being busy with other responsibilities, staff shortage, and proactively referring them to ophthalmologists for eye examinations, regardless of visual symptoms (15, 16). In these two studies, 43% of 42 PHC nurses in eThekwini and all PHC nurses in the Waterburg and Capricorn districts only perform case history taking, including referring patients with diabetes to ophthalmic nurses (15, 16).
4 Discussion
This narrative review found variations in HCPs’ knowledge, attitudes, and practices regarding diabetic retinopathy (DR). While these disparities may have been due to the differences in tools, settings, and research methodologies, some commonalities were noted. Not unexpectedly, the educational background of HCPs plays a crucial role; those who received specialized training in ophthalmic care, such as ophthalmologists, optometrists, and ophthalmic nurses, typically scored higher across all three domains than other categories of HCPs in three WHO regions, namely Africa, the Americas, and South East Asia (15, 16, 44, 47, 55, 56, 69, 72). Primary care physicians (PCPs) and general practitioners (GPs) demonstrated a good knowledge of DR occurring due to prolonged hyperglycemia and when to screen patients diagnosed with diabetes in the Eastern Mediterranean, South East Asia, and European regions (22–24, 29, 50, 52, 62, 66, 70).
Positive attitudes of HCPs are important in the success of screening programs for DR. Healthcare professionals with a positive disposition toward DR screening were more likely to refer diabetic patients for DR screening (8, 28, 39, 45). A combination of adequate knowledge and appropriate training on screening for DR has been shown to positively influence attitudes (45, 69). It is crucial for all HCPs, regardless of their specialty, to be familiar with the global protocols for DR screening and understand that they have a responsibility to either screen or refer diabetic patients for eye-related issues.
As with knowledge, the practice of referring diabetic patients for DR screening varied among different categories of HCPs across all six regions. Poor practice was related to either insufficient resources or a lack of expertise. Non-ophthalmic trained nurses did not have the practical skills needed to perform basic eye examinations. Research has shown that training of non-ophthalmic HCPs in DR screening can be effective in improving early detection and appropriate referral of patients (89, 90). Foundational training for non-ophthalmic HCPs at the first point of care should be a priority area in all healthcare settings serving diabetic patients. This training should include fundamental skills such as visual acuity testing, ophthalmoscopy or fundoscopy, and being aware of DR referral guidelines.
The lack of resources such as ophthalmoscopes and dilating eye drops also contributed to poor practices in some settings, especially amongst general practitioners. Interestingly, this finding was not restricted to studies from low and middle-income regions, such as Africa and the Eastern Mediterranean region, but also reported in studies from Europe and America (17, 18, 22, 44, 53). Furthermore, some HCPs reported having too many other responsibilities that resulted in insufficient screening for DR in patients with diabetes (21, 37). These gaps result in many patients not being screened or referred for screening. Implementing educational measures is crucial for improving DR screening processes and developing an effective referral network to ophthalmologists or optometrists for comprehensive eye examinations for all diabetic patients.
The use of more sophisticated medical technology, such as artificial intelligence fundus imaging and optical coherence tomography, has enhanced screening for DR. While this review did not focus on how screening was done, it must be noted that the use of these technologies may enable earlier and more accurate detection and timely treatment. These technologies are powered by automated retinal image analysis, which is also suitable for non-dilated pupils for fundoscopy to save time during DR screening.
This review has some limitations. It was limited to non-experimental research on HCPs’ knowledge, attitudes, and practices toward DR screening and referrals. The literature search was confined to electronic data sources. The review exhibited susceptibility to publication bias, as studies that yielded statistically significant results were more likely to be published, potentially distorting the overall findings. The study design and sampling methodologies may have influenced the validity of the findings. The results of studies that used non-random sampling or had low response rates may not reflect the KAP of all HCPs in that setting. Furthermore, practice was self-reported, including non-random samples, and this is likely to differ from the actual KAP. The heterogeneity of studies and samples poses a challenge in synthesizing the findings of the review. Whilst these limitations significantly influence the conclusions drawn from the reviewed articles, this review still has value in identifying the gaps in existing KAP amongst HCPs across regions.
5 Conclusion
There are important gaps in the knowledge, attitudes, and practices regarding DR screening among HCPs, particularly non-ophthalmic-trained HCPs. These HCPs have limited knowledge of the risk factors, early signs, and progression stages of DR, and attitudes that reflect that DR screening should be the responsibility of ophthalmic-trained HCPs only. Screening for DR was poorly practiced. The common reasons for these gaps were inadequate training, insufficient screening resources, and a high workload. Regular in-service training is needed to enhance screening and timely referrals, particularly for non-ophthalmic professionals. It is imperative that, even at the level of primary healthcare, appropriate resources are available so that patients at risk of DR can be screened and referred appropriately to reduce the burden of visual impairment and blindness due to DR.
Author contributions
KDM: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Validation, Visualization, Writing – original draft. SM: Conceptualization, Formal analysis, Methodology, Supervision, Validation, Writing – review & editing.
Funding
The author(s) declare that no financial support was received for the research and/or publication of this article.
Acknowledgments
We acknowledge the University of KwaZulu-Natal in South Africa for hosting this review paper. The authors also acknowledge the contribution of the two colleagues (Pebetese and Miyelani) working in the organization as KDM.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The authors declare that no Gen AI was used in the creation of this manuscript.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmed.2025.1536822/full#supplementary-material
References
1. World Health Organization. Health topics: disease and conditions, diabetes. (2023). Available online at: https://www.who.int (Accessed November 17, 2023).
2. International Diabetes Federation. What is diabetes? (2023). Available online at: https://idf.org (Accessed November 17, 2023).
3. Moradinazar, M, Babakhani, M, Rostami, R, Shakiba, M, Moradi, A, and Shakiba, E. Epidemiological status of type 2 diabetes mellitus in the Middle East and North Africa, 1990–2019. East Mediterr Health J. (2022) 28:478–88. doi: 10.26719/emhj.22.050
4. Cho, NH, Shaw, JE, Karuranga, S, Huang, Y, da Rocha Fernandes, JD, Ohlrogge, AW, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. (2018) 138:271–81. doi: 10.1016/j.diabres.2018.02.023
5. Bowling, B. Kanski’s clinical ophthalmology: a systematic approach. 8th ed. Sydney: Elsevier Limited (2016).
6. Spalton, DJ, Hitchings, RA, and Hunter, PA In: JCH Tan, editor. Atlas of clinical ophthalmology: revised reprint. 3rd ed. Mosby: Elsevier (2005)
7. American Academy of Ophthalmology. Common eye diseases and eye health topics: diabetic retinopathy. (2023). Available online at: https://www.aao.org
8. World Health Organization. Diabetic retinopathy screening: a short guide increase effectiveness, maximize benefits and minimize harm. (2021). Available online at: https://www.who.int (Accessed November 14, 2023).
9. Teo, ZL, Tham, YC, Yu, M, Chee, ML, Rim, TH, Cheung, N, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology. (2021) 128:1580–91. doi: 10.1016/j.ophtha.2021.04.027
10. Burgess, PI, Msukwa, G, and Beare, NAV. Diabetic retinopathy in sub-Saharan Africa: meeting the challenges of an emerging epidemic. BMC Med. (2013):11. doi: 10.1186/1741-7015-11-157
11. Al-Shehri, AM, Aldihan, KA, and Aljohani, S. Reasons for the late presentation of diabetic retinopathy in Saudi Arabia: a survey of patients who presented with advanced proliferative diabetic retinopathy to a tertiary eye hospital. Clin Ophthalmol. (2022) 16:4323–33. doi: 10.2147/opth.s394146
12. Elafros, MA, Callaghan, BC, Skolarus, LE, Vileikyte, L, Lawrenson, JG, and Feldman, EL. Patient and health care provider knowledge of diabetes and diabetic microvascular complications: a comprehensive literature review. Rev Endocr Metab Disord. (2023) 24:221–39. doi: 10.1007/s11154-022-09754-5
13. Barker, TH, Stone, JC, Sears, K, Klugar, M, Leonardi-Bee, J, Tufanaru, C, et al. Revising the JBI quantitative critical appraisal tools to improve their applicability: an overview of methods and the development process. JBI Evid Synth. (2023) 21:478–93. doi: 10.11124/JBIES-22-00125
14. DuBois, D, Richmond, R, Stephanie Roberts, L, Mahar, A, Fear, N, Gill, K, et al. A scoping review of military and veteran families within international suicidality and suicide prevention research. Prev Med Rep. (2023) 33:102206. doi: 10.1016/j.pmedr.2023.102206
15. Abdool, Z, Naidoo, K, and Visser, L. The management of diabetic retinopathy in the public sector of eThekwini district of KwaZulu-Natal. African Vision and Eye Health. (2016):75. doi: 10.4102/aveh.v75i1.344
16. Abdool, Z, Naidoo, K, and Visser, L. Competency level assessment of healthcare practitioners in managing diabetes and diabetic eye disease in the district health system of Limpopo province, South Africa. African Vision Eye Health. (2020) 79:1–6. doi: 10.4102/AVEH.V79I1.569
17. Abdulsalam, S, Ibrahim, A, Saidu, H, Muazu, M, Aliyu, U, Umar, H, et al. Knowledge, attitude, and practice of diabetic retinopathy among physicians in northwestern Nigeria. Niger J Clin Pract. (2018) 21:478–83. doi: 10.4103/njcp.njcp_266_17
18. Abu-Amara, TB, Al Rashed, WA, Khandekar, R, Qabha, HM, Alosaimi, FM, Alshuwayrikh, AA, et al. Knowledge, attitude, and practice among non-ophthalmic health care providers regarding eye management of diabetics in the private sector of Riyadh, Saudi Arabia. BMC Health Serv Res. (2019):19. doi: 10.1186/s12913-019-4216-9
19. Ahmed, I, Alosaimi, M, Alghamdi, M, Alqarawi, A, Alzahrani, S, Almutairi, M, et al. Diabetic retinopathy knowledge, awareness and practices of physicians in primary health care centers. Int J Pharm Res Allied Sci. (2020) 9:63–9.
20. Al Rasheed, R, and Al, AF. Diabetic retinopathy: knowledge, awareness, and practices of physicians in primary care centers in Riyadh, Saudi Arabia. Saudi J Ophthalmol. (2017) 31:2–6. doi: 10.1016/j.sjopt.2017.01.001
21. Alanazi, FS, Merghani, TH, Alghthy, AM, and Alyami, RH. An assessment of knowledge, attitude, and practice towards diabetic retinopathy among general practitioners of Tabuk City. Egypt J Hosp Med. (2018) 73:6655–60. doi: 10.21608/ejhm.2018.15857
22. Alasqah, A, Aldosari, F, and Almutaz, A. Primary care physicians’ knowledge, attitudes, and practices related to diabetic retinopathy in Buraidah city, Qassim region, Saudi Arabia. Saudi J Health Sci. (2020) 9:152. doi: 10.4103/sjhs.sjhs_46_20
23. Al Ghamdi, A, Rabiu, M, Al Qurashi, A, Al Zaydi, M, Al Ghamdi, A, Gumaa, S, et al. Knowledge, attitude, and practice pattern among general health practitioners regarding diabetic retinopathy Taif, Kingdom of Saudi Arabia. Saudi J Health Sci. (2017) 6:44. doi: 10.4103/2278-0521.210820
24. Alhejji, AE, Alsultan, MA, Alshareet, MA, Alkhamis, FA, Aljaafary, MA, Alshaqaqiq, AI, et al. Knowledge, attitudes, and practices regarding diabetic retinopathy among primary health care physicians in Al-Hasa, Saudi Arabia. J Prev Med Hyg. (2020) 61:E85–91. doi: 10.15167/2421-4248/jpmh2020.61.1.1229
25. Almotairy, FM, Almutairi, MS, Bamhair, AS, Bagazi, GA, Alolayan, OK, Alsuqayh, TA, et al. Awareness and attitude regarding diabetic retinopathy among physicians in Riyadh, Saudi Arabia. Med Sci. (2021) 25:3382–91.
26. Al-Rashidi, SH, Al-Thunayyan, FS, Alsuhaibani, KA, Alharbi, AA, and Alharbi, KA. Knowledge and practices of fundoscopy among general practitioners in Qassim Province, Saudi Arabia, for the management of diabetic retinopathy and diabetic macular edema: a cross-sectional study. SAGE Open Med. (2020):8. doi: 10.1177/2050312119900863
27. Alsaedi, MG, Alhujaili, HO, Fairaq, GS, Alwdaan, SA, and Alwadan, RA. Emergent ophthalmic disease knowledge among non-ophthalmologist healthcare professionals in the Western region of Saudi Arabia: cross-sectional study. Open Ophthalmol J. (2022) 16:1–11. doi: 10.2174/18743641-v16-e2203160
28. Alzaidi, MM, Saeedalmalki, H, and Alghamdi, GM. Assessing the knowledge, attitudes, and practice of diabetic complications among physicians in Taif, Saudi Arabia. Egypt J Hosp Med. (2016) 65:693–5. doi: 10.12816/0033784
29. Anwar, MS, Shakaib, B, Akhtar, W, Yusufzai, E, Zehra, M, Munawar, H, et al. Knowledge and practices of primary care physicians on the current referral system of diabetic retinopathy in Islamabad and Rawal-Pindi, Pakistan. Int J Ophthalmol. (2019) 12:1885–92. doi: 10.18240/ijo.2019.12.11
30. Babelgaith, SD, Alfadly, S, and Baidi, M. Assessment of the attitude of health care professionals towards diabetes care in Mukalla, Yemen. Int J Public Health Sci (IJPHS). (2013) 2:159–64.
31. Babu, M, Adyanthaya, S, and Abhilash, B. Assessment of knowledge, attitude, and practice of diabetic eye care among non-ophthalmic specialty doctors at a tertiary institute in India. Indian J Clin Exp Ophthalmol. (2021) 7:676–80. doi: 10.18231/j.ijceo.2021.136
32. Bogunjoko, TJ. Knowledge, attitude, and practices among medical officers and diabetic patients regarding diabetic retinopathy in Ogun state of Nigeria. J Ophthalmol Eastern Central Southern Africa. (2015) 1:27–33.
33. Barakat, AA, Mobarak, O, Javaid, HA, Awad, MR, Hamweyah, K, Ouban, A, et al. The application of artificial intelligence in diabetic retinopathy screening: a Saudi Arabian perspective. Front Med (Lausanne). (2023) 10:1303300. doi: 10.3389/fmed.2023.1303300
34. Carlos Preti, R, Saraiva, F, Artur Trein Junior, J, Takahashi, WY, Rossi, E, da Silva Preti, MR, et al. Clinical science how much information do medical practitioners and endocrinologists have about diabetic retinopathy? Clinics. (2007) 62:273–81. doi: 10.1590/S1807-59322007000300011
35. Chelliah, R, Rangasamy, R, Mahalingam, K, Ramani, S, Sriram, S, and Ganesh, V. Awareness about diabetic retinopathy among doctors not specialized in ophthalmology. TNOA J Ophthal Sci Res. (2019) 57:199. doi: 10.4103/tjosr.tjosr_56_19
36. Daly, B, Arroll, B, Sheridan, N, Kenealy, T, and Scragg, R. Diabetes knowledge of nurses providing community care for diabetes patients in Auckland, New Zealand. Prim Care Diabetes. (2014) 8:215–23. doi: 10.1016/j.pcd.2014.01.001
37. Delorme, C, Boisjoly, HM, Baillargeon, L, Turcotte, P, and Bernard, P-M. Screening for diabetic retinopathy do family physicians know the Canadian guidelines? Can Fam Physician. (1998) 4:1472–9.
38. Dickson, PR, McCarty, CA, Keeffe, JE, Baxter, R, Harper, CA, Taylor, HR, et al. Diabetic retinopathy: examination practices and referral patterns of general practitioners. Med J Aust. (1996) 164:341–4. doi: 10.5694/j.1326-5377.1996.tb122049.x
39. Edwiza, D, Sovani, I, and Ratnaningsih, N. Correlation between knowledge and attitudes with the practices of general practitioners regarding diabetic retinopathy in primary health care in Bandung. J Clin Ophthalmol Optomet Res. (2021) 1:1–7.
40. Elnagieb, F, and Saleem, M. Knowledge, attitudes, and practices on diabetic retinopathy among medical residents and general practitioners in Khartoum, Sudan. Al-Basar Int J Ophthalmol. (2017) 4:66. doi: 10.4103/bijo.bijo_4_17
41. Erdem, S. Diabetic retinopathy knowledge and management approaches of primary care physicians. Ann Med Res. (2020) 27:674. doi: 10.5455/annalsmedres.2019.12.887
42. Fernández-Gutiérrez, DÁ, Núñez-Marrero, J, Martínez-Alberto, CE, Rodríguez-Álvaro, M, García-Hernández, AM, and Brito-Brito, PR. Knowledge of diabetic retinopathy among primary care nurses performing fundus photography and agreement with ophthalmologists on screening. Nurs Rep. (2023) 13:1064–76. doi: 10.3390/nursrep13030093
43. Fatima, I, and Ahmad, I. Knowledge, attitude, and practice (KAP) study regarding optometric services among general practitioners in Lahore. Ophthalmology. (2018) 8:14–17.
44. Foster, DT, Wylie-Rosett, J, and Walker, EA. Local survey of optometrists about dilated funduscopic examinations for patients with diabetes: making use of phone book yellow-page listings. Diab Educ. (1996) 22:605–8. doi: 10.1177/014572179602200609
45. George, PP, Yun, OCS, Siow, K, Saxena, N, Heng, BH, Car, J, et al. Is there scope for expanding the optometrist’s scope of practice in Singapore? – A survey of optometrists, and opticians in Singapore. Contact Lens Anterior Eye. (2019) 42:258–64. doi: 10.1016/j.clae.2019.02.008
46. Gharsangi, K, Himral, P, and Bhawani, R. Knowledge, attitude, and practices regarding diabetes and its complications among health care workers in medical college of North India. Int J Collab Res Intern Med Public Health. (2021) 13:1–7.
47. Ghosh, S, Mukhopadhyay, S, Maji, D, and Halder, D. Awareness of diabetic retinopathy among physicians and optometrists in a district of West Bengal. Indian J Public Health. (2007) 51:228–230.
48. Goodman, G, Zwarenstein, M, Robinson, I, and Levitt, N. Staff knowledge, attitudes, and practices in the public sector primary care of diabetes. S Afr Med J. (1997) 87:305–309.
49. El Hajj, MS, Abu Yousef, SE, and Basri, MA. Diabetes care in Qatar: a survey of pharmacists’ activities, attitudes, and knowledge. Int J Clin Pharm. (2018) 40:84–93. doi: 10.1007/s11096-017-0562-z
50. Hipwell, A, Lindenmeyer, A, Stratton, I, Gadsby, R, O’Hare, P, and Scanlon, P. Attitudes, access, and anguish: a qualitative interview study of staff and patients’ experience of diabetic retinopathy. BMJ Open. (2014) 1:1–69.
51. Jagun, O, Imishue, O, Adebusoye, S, Betiku, A, and Oluwolle, A. Attitudes, and perception of healthcare professionals in Ogun state towards their visual health. Int J Res Granthaalayah. (2020) 8:185–91. doi: 10.29121/granthaalayah.v8.i7.2020.728
52. Khan, AT, Lateef, NAA, Khamseen, MB, Al Aithan, M, Khan, SA, and Al, II. Knowledge, attitude, and practice of the Ministry of Health primary health care physicians in the management of type 2 diabetes mellitus: A cross-sectional study in the Al Hasa District of Saudi Arabia, 2010. Niger J Clin Pract. (2011) 14:52–9. doi: 10.4103/1119-3077.79241
53. Khandekar, R, Shah, S, and Al-Lamatti, J. Retinal examination of diabetic patients: knowledge, attitudes, and practices of physicians in Oman. East Mediterr Health J. (2008) 14:850–857.
54. Kiely, PM, Cappuccio, S, and McIntyre, E. Optometry Australia scope of practice survey 2015. Clin Exp Optom. (2017) 100:260–9. doi: 10.1111/cxo.12538
55. Kumar, S, Kumar, G, Velu, S, Pardhan, S, Sivaprasad, S, Ruamviboonsuk, P, et al. Patient and provider perspectives on barriers to screening for diabetic retinopathy: an exploratory study from southern India. BMJ Open. (2020) 10:e037277. doi: 10.1136/bmjopen-2020-037277
56. Kumar, G, Velu, S, Pardhan, S, Sapkota, R, Ruamviboonsuk, P, Tadarati, M, et al. Patient, family member, and health care provider perspective on barriers and facilitators to diabetic retinopathy screening in Thailand: a qualitative study. PLoS One. (2023) 18:e0289618. doi: 10.1371/journal.pone.0289618
57. Kupitz, DG, Fenwick, E, Kollmann, KHM, Holz, FG, and Finger, RP. Diabetes and diabetic retinopathy Management in East Africa. Asia-Pacific J Ophthalmol. (2014) 3:271–6. doi: 10.1097/APO.0b013e3182a83bfa
58. Lestari, YD, Adriono, GA, Ratmilia, R, Magdalena, C, and Sitompul, R. Knowledge, attitude, and practice patterns towards diabetic retinopathy screening among general practitioners in primary health centers in Jakarta, the capital of Indonesia. BMC Primary Care. (2023):24. doi: 10.1186/s12875-023-02068-8
59. Malik, MB, Ali Chippa, S, Rashid, A, and Akram, S. Awareness and referral attitudes of diabetic retinopathy among surgeons at a tertiary care hospital in Pakistan. Pakistan J Ophthalmol. (2023) 39:233–8. doi: 10.36351/pjo.v39i3.1553
60. McCarty, CA, McKay, R, and Keeffe, JE. Management of diabetic retinopathy by Australian ophthalmologists. Clin Experiment Ophthalmol. (2000) 28:107–12. doi: 10.1046/j.1442-9071.2000.00272.x
61. Mensah, V. Knowledge, attitudes, and practices of diabetic retinopathy among medical officers in the regional hospitals of Ghana. [Dissertation Master of Medicine (Ophthalmology)] University of Nairobi.
62. Muecke, JS, Newland, HS, Ryan, P, Ramsay, E, Aung, M, Myint, S, et al. Awareness of diabetic eye disease among general practitioners and diabetic patients in Yangon, Myanmar. Clin Experiment Ophthalmol. (2008) 36:265–73. doi: 10.1111/j.1442-9071.2008.01724.x
63. Namperumalsamy, P, Kim, R, Kaliaperumal, K, Sekar, A, Karthika, A, and Nirmalan, P. A pilot study on awareness of diabetic retinopathy among non-medical persons in South India. The challenge for eye care programmes in the region. Indian J Ophthalmol. (2004) 52:247–51.
64. Niyonsavye, L. Knowledge, attitudes, and practices on diabetic retinopathy among general practitioners in district and regional hospitals in the north region of Burundi. [Thesis] University of Nairobi (2015).
65. Oenga, RB. Diabetic retinopathy; knowledge, attitudes, and practice among general practitioners in provincial hospitals in Kenya. [Dissertation Master of Medicine (Ophthalmology)] University of Nairobi (2012).
66. Pradhan, E, Khatri, A, Tuladhar, J, and Shrestha, D. Diabetic eye disease related knowledge, attitudes and practices among physicians in Nepal. J Diab Endocrinol Assoc Nepal. (2018) 2:26–36.
67. Ram, S, Mohammadnezhad, M, Ram, K, Dalmia, P, and Pal, M. Impact of diabetic retinopathy awareness training on community health workers’ knowledge and referral practices in Fiji: a qualitative study. Rural Remote Health. (2022) 22:1–10. doi: 10.22605/RRH6976
68. Raman, R, and George, PP. Knowledge, and attitude of general practitioners towards diabetic retinopathy practice in South India: an inexpensive tool for routine fundus examination at primary eye care centers. Commun Eye Health J. (2006) 19:13.
69. Shah, M, Noor, A, Ormsby, GM, Chakrabarti, R, Harper, CA, Islam, FA, et al. Attitudes, and perceptions of eye care workers and health administrators regarding task sharing in screening and detection for management of diabetic retinopathy in Pakistan. Ophthalmic Epidemiol. (2018) 25:169–75. doi: 10.1080/09286586.2017.1381273
70. Thirunavukkarasu, A, Almulhim, AK, Albalawi, FA, Alruwaili, ZM, Almajed, OA, Alruwaili, SH, et al. Knowledge, attitudes, and practices towards diabetic retinopathy among primary care physicians of Saudi Arabia: a multicenter cross-sectional study. Healthcare (Switzerland). (2021) 9:1697. doi: 10.3390/healthcare9121697
71. Wright, SE, McKay, R, Taylor, KI, Keeffe, JE, McCarty, CA, et al. Changes in attitudes and practices of optometrists in the management of diabetic retinopathy after the release of NHMRC guidelines. Clin Experiment Ophthalmol. (2001) 29:121–4. doi: 10.1046/j.1442-9071.2001.00390.x
72. Xulu-Kasaba, Z, Mashige, K, and Naidoo, K. Knowledge, attitudes, and practices of eye health among public sector eye health workers in South Africa. Int J Environ Res Public Health. (2021):18. doi: 10.3390/ijerph182312513
73. Yan, X, Liu, T, Gruber, L, Mingguang He, B, and Congdon, N. Attitudes of physicians, patients, and village health workers toward Glaucoma and diabetic retinopathy in rural China A focus group study. Arch Ophthalmol. (2012) 130:761–70. doi: 10.1001/archophthalmol.2012.145
74. Munn, Z, Stone, JC, Aromataris, E, Klugar, M, Sears, K, Leonardi-Bee, J, et al. Assessing the risk of bias of quantitative analytical studies: introducing the vision for critical appraisal within JBI systematic reviews. JBI Evid Synth. (2023) 21:467–71. doi: 10.11124/JBIES-22-00224
75. Khalil, H, Bennett, M, Godfrey, C, McInerney, P, Munn, Z, and Peters, M. Evaluation of the JBI scoping reviews methodology by current users. Int J Evid Based Healthc. (2019). 18:95–100. doi: 10.1097/XEB.0000000000000202
76. George, P, Decastro Molina, J, and Heng, B. The methodological quality of systematic reviews comparing intravitreal bevacizumab and alternates for neovascular age related macular degeneration: a systematic review of reviews. Indian J Ophthalmol. (2014) 62:761–7. doi: 10.4103/0301-4738.138615
77. Hadlaq, A-A, A, AL-M, Al-Ali, A, Al-Rashidi, I, and Iqbal, Z. Knowledge, attitude, and practice study about retinopathy of prematurity among pediatricians in Al-Qassim region, Saudi Arabia. Int J Med Dev Countries. (2021):1290–5. doi: 10.24911/IJMDC.51-1619901584
78. Alenezi, SH. Knowledge, attitude, and practice of final year medical students and interns on diabetic retinopathy in Saudi Arabia. Pakistan J Med Health Sci. (2022) 16:1309–12. doi: 10.53350/pjmhs221651309
79. Alharbi, M, Almazyad, M, Alatni, B, Alharbi, B, and Alhadlaq, A. Medical students’ knowledge, attitudes, and practices concerning diabetes-related retinopathy. J Family Med Prim Care. (2020) 9:1058. doi: 10.4103/jfmpc.jfmpc_898_19
80. Alhazimi, A. Knowledge, attitude, and practice on diabetic retinopathy among final-year medical students in Riyadh. J Pharm Bioallied Sci. (2024). 16:1–6. doi: 10.4103/jpbs.jpbs_604_23
81. Althiabi, S, Althwiny, F, Alshutily, A, and Aljbreen, A. The knowledge, attitude, and practice regarding diabetes and diabetic retinopathy among the medical students in Qassim university. Int J Med Dev Countries. (2021):1034–9. doi: 10.24911/ijmdc.51-1612391795
82. Al-Wadaan, F. The knowledge, attitude, and practice regarding diabetes and diabetic retinopathy among final-year medical students of King Faisal University Medical College of Al-Hasa region of Saudi Arabia. Niger J Clin Pract. (2013) 16. doi: 10.4103/1119-3077.110133
83. Al-Wadaan, F. Nursing students perceived knowledge, attitudes, and practices concerning ocular complications of diabetes. Int J Innov Res Multidis Field. (2016) 2:119–28.
84. Dareshani, S, Farooq, F, Ali, MA, Khan, NS, and Sultan, Z. Knowledge, attitude and practice about diabetic retinopathy among medical students. Pakistan J Ophthalmol. (2022) 38:71–5. doi: 10.36351/pjo.v38i1.1299
85. David, E, Aderemi-Williams, R, Nasiru, I, and Abad, I. Pharmacists’ knowledge, attitudes, and perceptions in the prevention and management of diabetic microvascular complications. Highland Med Res. (2016) 16:11–16.
86. Shetty, NK, and Swapnika, S. KAP study on diabetic retinopathy amongst the paramedic nursing students. Indian J Clin Exp Ophthalmol. (2017) 3:85–90. doi: 10.18231/2395-1451.2017.0022
87. Wanyama, S. Knowledge, attitudes, and practices of eye diseases in children among pediatricians in Kenya. [Thesis]. University of Nairobi. (2011).
88. Ammary-Risch, NJ, Aguilar, M, Goodman, LS, and Quiroz, L. Diabetes and healthy eyes toolkit: a community health worker program to prevent vision loss and blindness among people with diabetes. Fam Community Health. (2012) 35:103–10. doi: 10.1097/FCH.0b013e3182464fc0
89. Rani, PK, Takkar, B, and Das, T. Training of nonophthalmologists in diabetic retinopathy screening. Indian J Ophthalmol. (2021) 69:3072–5. doi: 10.4103/ijo.IJO_1117_21
Keywords: knowledge, attitudes, practice, diabetic, retinopathy, complications, healthcare professionals
Citation: Maluleke KD and Mahomed S (2025) A narrative review of the knowledge, attitudes, and practices of healthcare professionals toward diabetic retinopathy. Front. Med. 12:1536822. doi: 10.3389/fmed.2025.1536822
Edited by:
Georgios D. Panos, Aristotle University of Thessaloniki, GreeceReviewed by:
Siti Nurliyana Abdullah, Raja Isteri Pengiran Anak Saleha Hospital, BruneiAlan Rubin, University of Johannesburg, South Africa
Copyright © 2025 Maluleke and Mahomed. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Khisimusi Debree Maluleke, a2RlYnJlZUB5YWhvby5jb20=